pharma · Recurrent Respiratory Tract Infections · Actinic Keratosis on the Face or Scalp
ALMIRALL S.P.A
Almirall, S.A.
ALMIRALL S.P.A is a pharma organization headquartered in Barcelona, IT. Primary therapeutic focus areas include Recurrent Respiratory Tract Infections, Actinic Keratosis on the Face or Scalp, Alopecia areata, Actinic Ker
VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona HQ
2 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona
- Employees
- 2
- Programs
- 11
- Drugs
- 20
- Patents
- 308
Pidotimod
Approved · small molecule · Recurrent Respiratory Tract Infections
Pidotimod for Recurrent Respiratory Tract Infections is a Approved program (small_molecule) at Almirall, S.A. with 1 ClinicalTrials.gov record(s).
Internal code M-PIMOT-40
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Almirall, S.A.
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Recurrent Respiratory Tract Infections
- Status
- completed
- Trials
- 1